RecruitingNCT05101382
A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
Sponsor
IFOM ETS - The AIRC Institute of Molecular Oncology
Enrollment
500 participants
Start Date
Oct 28, 2020
Study Type
OBSERVATIONAL
Summary
ALFAOMEGA-RETRÒ will be exploited to retrospectively collect clinical and imaging data and archival samples to be used for validation and correlative studies on markers discovered by cutting-edge translational projects within the AIRC5x1000 program "Insights into the evolving heterogeneity of colorectal cancer (CRC): from mechanism to therapies" (an ongoing multi-institutional research program).
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Histologically-confirmed diagnosis of colorectal cancer (any stage).
- Age \>18 years at the time of diagnosis.
- Availability of clinically-annotated radio-imaging data and/or diagnostic Formalin-Fixed Paraffin Embedded (FFPE) blocks (surgical resections and/or tumor biopsies), or at least 10 slides (preferably 20). FFPE tissue blocks are always preferred to slides.
- Verification that the patient could not be reached for informed consent in accordance with applicable national regulations.
Interventions
OTHERObservation
Retrospective Observation of standard clinical practice
Locations(13)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05101382